Literature DB >> 636997

Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis.

B H Bulkley, P G Klacsmann, G M Hutchins.   

Abstract

The syndrome of angina pectoris or acute myocardial infarction without obstructive coronary artery disease has been the subject of much interest. We studied nine autopsied patients with progressive systemic sclerosis and evidence of ischemic heart disease but morphologically normal coronary arteries. Three patients had angina pectoris and three others chest pains of unknown etiology, six had ventricular arrhythmias, four had clinically suspected acute myocardial infarction, and eight had sudden cardiac death. At autopsy extensive focal myocardial necrosis was present in seven patients and myocardial scarring in all nine, but all patients had widely patent intramural and extramural coronary arteries. The finding of contraction band myocardial necrosis in seven of the eight patients who experienced sudden death suggests that the myocardial damage was a consequence of reperfusion of focally nonperfused myocardium, and thus due to a myocardial Raynaud's phenomenon. Patients with PSS may provide a model of spasm of intramyocardial vessels causing angina pectoris or myocardial infarction with morphologically normal coronary arteries.

Entities:  

Mesh:

Year:  1978        PMID: 636997     DOI: 10.1016/0002-8703(78)90297-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Acute myocardial infarction in systemic sclerosis patients: a case series.

Authors:  Chris T Derk; Sergio A Jimenez
Journal:  Clin Rheumatol       Date:  2006-03-07       Impact factor: 2.980

2.  Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow.

Authors:  J M Walker; P T Wilmshurst; S M Juul; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

3.  Interrelation of heart rate and autonomic activity in asymptomatic men with unobstructed coronary arteries. Studies with atrial pacing, adrenaline infusion, and autonomic blockade.

Authors:  P Taggart; R Donaldson; J Green; S P Joseph; H B Kelly; J Marcomichelakis; D Noble; J White
Journal:  Br Heart J       Date:  1982-01

Review 4.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

5.  Clinicopathological study of myocardial infarction with normal or nearly normal extracardiac coronary arteries. Quantitative analysis of contraction band necrosis, coagulation necrosis, hemorrhage, and infarct size.

Authors:  D J Wu; H Fujiwara; M Matsuda; M Ishida; A Kawamura; G Takemura; M Kida; T Uegaito; T Fujiwara; C Kawai
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

6.  Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma.

Authors:  A Kahan; J Y Devaux; B Amor; C J Menkes; S Weber; J M Foult; A Venot; F Guerin; M Degeorges; J C Roucayrol
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

7.  Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study.

Authors:  C Ferri; V Di Bello; A Martini; D Giorgi; F A Storino; M Bianchi; A Bertini; M Paterni; C Giusti; G Pasero
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

Review 8.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

9.  Non-invasive assessment of early cardiac involvement in systemic sclerosis.

Authors:  G S Butrous; P M Dowd; J Milne; D S Dymond; J Caplin; A J Camm
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 10.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.